|
Dec 20
|
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
|
|
Dec 20
|
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
|
|
Dec 20
|
4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
|
|
Dec 19
|
Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings
|
|
Dec 19
|
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
|
|
Dec 19
|
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
|
|
Dec 8
|
Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study
|
|
Dec 8
|
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?
|
|
Dec 8
|
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
|
|
Dec 7
|
Pharvaris (PHVS) Stock Up 18% on HAE Drug Meeting Study Goal
|
|
Dec 7
|
Sanofi (SNY) Posts Upbeat Long-Term Outlook, Enhances R&D Focus
|
|
Dec 7
|
Is It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?
|
|
Dec 7
|
AbbVie (ABBV) to Acquire Cerevel Therapeutics (CERE) for $8.7B
|
|
Dec 6
|
J&J (JNJ) Announces 2024 and Long-Term Financial Outlook
|
|
Dec 6
|
Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study
|
|
Dec 5
|
Pfizer’s Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals
|
|
Dec 5
|
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
|
|
Dec 5
|
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline
|
|
Dec 5
|
J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag
|
|
Dec 5
|
Novo Nordisk seeks to use obesity drug findings to prevent weight gain
|